![]() |
|
|
Vol. 303, Issue 2, 439-444, November 2002
Department of Pharmacology, University of Nevada School of
Medicine, Reno Nevada
ATP and norepinephrine (NE) are cotransmitters released from many
postganglionic sympathetic nerves. In this article, we review the
evidence for ATP and NE cotransmission in the rodent vas deferens with
special attention to the mechanisms involved in removing the
cotransmitters from the neuroeffector junction. Although the clearance
of NE is well understood (e.g., the primary mechanism being reuptake
into the nerves), the clearance of ATP is just beginning to be
explained. The general belief has been that ATP is metabolized by
cell-fixed ecto-nucleotidases. It now seems, however, that when ATP is
released from nerves as a transmitter there is a concomitant release of
nucleotidases that rapidly degrade ATP sequentially to ADP, AMP, and
adenosine, thereby terminating the action of ATP. In the guinea pig vas
deferens, there appear to be at least two enzymes, one that converts
ATP to ADP and ADP to AMP (an ATPDase) and a second enzyme that
converts AMP to adenosine (an AMPase). An important feature of this
process is that the transmitter-metabolizing nucleotidases are released
into the synaptic space as opposed to being fixed to cell membranes. A
preliminary characterization of these enzymes suggests that the
releasable ATPDase exhibits some similarities to known ectonucleoside
triphosphate/diphosphohydrolases, whereas the releasable AMPase
exhibits some similarities to ecto-5'-nucleotidases.
This article has been cited by other articles:
![]() |
J. Ren, Z. Mi, and E. K. Jackson Assessment of Nerve Stimulation-Induced Release of Purines from Mouse Kidneys by Tandem Mass Spectrometry J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 920 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Park, J. J. Galligan, G. D. Fink, and G. M. Swain Differences in sympathetic neuroeffector transmission to rat mesenteric arteries and veins as probed by in vitro continuous amperometry and video imaging J. Physiol., November 1, 2007; 584(3): 819 - 834. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Schaefer, T. Machida, M. J. Broekman, A. J. Marcus, and R. Levi Targeted Deletion of Ectonucleoside Triphosphate Diphosphohydrolase 1/CD39 Leads to Desensitization of Pre- and Postsynaptic Purinergic P2 Receptors J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1269 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Lomax, M. O'Reilly, S. Neshat, and S. J. Vanner Sympathetic vasoconstrictor regulation of mouse colonic submucosal arterioles is altered in experimental colitis J. Physiol., September 1, 2007; 583(2): 719 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. del Rey, V. Renigunta, A. H. Dalpke, J. Leipziger, J. E. Matos, B. Robaye, M. Zuzarte, A. Kavelaars, and P. J. Hanley Knock-out Mice Reveal the Contributions of P2Y and P2X Receptors to Nucleotide-induced Ca2+ Signaling in Macrophages J. Biol. Chem., November 17, 2006; 281(46): 35147 - 35155. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Buvinic, M. I. Poblete, M. V. Donoso, A. M. Delpiano, R. Briones, R. Miranda, and J. P. Huidobro-Toro P2Y1 and P2Y2 receptor distribution varies along the human placental vascular tree: role of nucleotides in vascular tone regulation J. Physiol., June 1, 2006; 573(2): 427 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Schuh, A. E. Carlson, G. S. McKnight, M. Conti, B. Hille, and D. F. Babcock Signaling Pathways for Modulation of Mouse Sperm Motility by Adenosine and Catecholamine Agonists Biol Reprod, March 1, 2006; 74(3): 492 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lee, D.-J. Jun, B.-C. Suh, B.-H. Choi, J.-H. Lee, M.-S. Do, B.-S. Suh, H. Ha, and K.-T. Kim Dual Roles of P2 Purinergic Receptors in Insulin-stimulated Leptin Production and Lipolysis in Differentiated Rat White Adipocytes J. Biol. Chem., August 5, 2005; 280(31): 28556 - 28563. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Machida, P. M. Heerdt, A. C. Reid, U. Schafer, R. B. Silver, M. J. Broekman, A. J. Marcus, and R. Levi Ectonucleoside Triphosphate Diphosphohydrolase1/CD39, Localized in Neurons of Human and Porcine Heart, Modulates ATP-Induced Norepinephrine Exocytosis J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 570 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Donoso, R. Lopez, R. Miranda, R. Briones, and J. P. Huidobro-Toro A2B adenosine receptor mediates human chorionic vasoconstriction and signals through arachidonic acid cascade Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2439 - H2449. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kukley, P. Stausberg, G. Adelmann, I. P. Chessell, and D. Dietrich Ecto-Nucleotidases and Nucleoside Transporters Mediate Activation of Adenosine Receptors on Hippocampal Mossy Fibers by P2X7 Receptor Agonist 2'-3'-O-(4-Benzoylbenzoyl)-ATP J. Neurosci., August 11, 2004; 24(32): 7128 - 7139. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Queiroz, C. Talaia, and J. Goncalves ATP Modulates Noradrenaline Release by Activation of Inhibitory P2Y Receptors and Facilitatory P2X Receptors in the Rat Vas Deferens J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 809 - 815. [Abstract] [Full Text] [PDF] |
||||